Patents by Inventor Max P. Seiler

Max P. Seiler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical active 1,2,3,4,4A,5,10,10A-octahydrobenzo[g] quinoline derivatives, and their use
    Patent number: 4692453
    Abstract: A 6- or 8-monooxy- or 6,8-dioxy-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline in which the 3-position is unsubstituted, is useful as a pharmaceutical, in particular as a prolactin secretion inhibitor, dopaminergic agent and dopamine receptor stimulating agent.
    Type: Grant
    Filed: November 13, 1985
    Date of Patent: September 8, 1987
    Assignee: Sandoz Ltd.
    Inventor: Max P. Seiler
  • Indolophenanthridines useful as dopaminergic and analgesic agents
    Patent number: 4634708
    Abstract: 4,6,6a,7,8,12b-hexahydro-indolo[4,3-ab]phenanthridines are useful as dopaminergic and analgesic agents.
    Type: Grant
    Filed: January 25, 1985
    Date of Patent: January 6, 1987
    Assignee: Sandoz Ltd.
    Inventors: Alexander Hagenbach, Max P. Seiler, Hans J. Wuthrich
  • Tetraline derivatives, their production and pharmaceutical compositions containing them
    Patent number: 4410519
    Abstract: An optically active or racemic 2-amino-5-hydroxy-1,2,3,4-tetrahydronaphthalene wherein the nitrogen atom of the amino group carrier two alkyl groups, one of which is unsubstituted and the other is substituted by at least one functional group, or a physiologically hydrolysable ester thereof in free base form or in the form of an acid addition salt thereof is provided which is active against heart circulatory disorders and Morbus Parkinson and inhibits prolactin secretion inhibition.
    Type: Grant
    Filed: March 12, 1981
    Date of Patent: October 18, 1983
    Assignee: Sandoz Ltd.
    Inventors: Max P. Seiler, Andre Stoll